Integral Diagnostics (IDX) Competitors

Nucleus Network is the only global provider dedicated to early phase clinical trials, with units in Australia, the USA and the UK. Our unified network provides sponsors access to all three major regulatory markets through one trusted partner. With more than 2,500 early phase studies and 1,500 First in Human trials over 30 years, we are the most experienced early phase team worldwide. We are recognised for managing complex and adaptive designs with confidence, supported by proven scientific leadership and operational delivery. Alongside First in Human expertise, we conduct the full spectrum of clinical pharmacology studies, giving sponsors the depth, consistency and participant access to accelerate new medicines. One Network. Multiple Pathways. The Power of a Unified Global Network.

Sonic HealthPlus is Australia’s leading integrated healthcare provider with ~40 wholly-owned clinics operating in metropolitan, regional and remote locations across the country. Proudly Australian, we are backed financially and logistically by Global ASX Top 50 listed company, Sonic Healthcare – a world-leading medical diagnostic company and operator of the largest network of primary care medical centres across the nation. Our service delivery is led by multidisciplinary teams of accredited doctors, nurses and allied health practitioners with over 30 years of expertise in workplace health and safety. Sonic HealthPlus offers a range of in-clinic, on-site and specialist occupational and community services to help keep Australians safe, healthy and productive including: • Drug and Alcohol Screening • Pre-Employment and Legislative Medicals • Health Surveillance • Injury Management, Treatment and Prevention • Onsite Medical Services • Workplace Health and Wellness

Primary Health Care is one of Australia's leading publically listed healthcare companies. The Primary network is comprised of four core business divisions of pathology, medical centres, diagnostic imaging and Health & Co. Primary employs more than 12,000 people across 2,500 sites and has been providing quality, affordable and accessible healthcare to the people of Australia for more than 30 years. The Primary pathology business, operating through the subsidiary, Specialist Diagnostic Services (SDS), is an amalgamated business comprised of a number of well-established brands with a strong local presence, as well as niche diagnostic businesses specialising in the areas of IVF, dermatopathology and genetics. Some of our brands include Laverty Pathology, QML Pathology, Western Diagnostic Pathology, Dorevitch Pathology, Tasmanian Medical Laboratories, Abbott Pathology and Kossard Dermatopathologists. The Primary network ensures a comprehensive, national service dedicated to patient and doctor centricity, and innovation. 1 in every 3 pathology samples taken in Australia are tested in our laboratories. We have over 8,000 team members - a mix of pathologists, phlebotomists, scientists, laboratory assistants, couriers and support employees working across around 2,300 sites across the country, including 109 laboratories.